INSIGHTS ON SOLID DOSE MANUFACTURING

• Optimising Solubility: Selecting The Right Technology For Early Drug Development

  Discover how selecting the right solubility‑enhancing technology improves early exposure, supports flexible dosing, and lays a strong foundation for downstream oral drug development.

• Enabling Complex Phase IIa Dosing Through Flexible Clinical Packaging Design

  Discover how flexible, patient‑centric clinical packaging supports complex Phase IIa dosing while protecting timelines, ensuring compliance, and avoiding costly primary packaging changes.

• The Importance Of Polymorph Screenings

  Discover how systematic polymorph screening reduces development risk, safeguards product performance, and enables confident solid‑form selection across the drug development lifecycle.

• A Simple And Powerful Solution For Accelerating Dissolution

  Many poorly soluble drugs fail not because of low solubility, but because they dissolve too slowly. Learn how focusing on dissolution rate can unlock absorption gains using simple strategies.

• Safely Scaling High Potency API Manufacturing

  4/13/2026

  Scaling HPAPI production demands disciplined containment and exposure control. Integrated operating models help manage risk while enabling compliant, reliable scale‑up.

• Developing And Manufacturing Drugs With HPAPIs

  1/27/2025

  Learn why companies must invest in specialized expertise to develop scalable, safe, and efficient manufacturing processes for highly potent oral solid dose products.

• Fundamentals Of Power Blending Simulations

  2/26/2025

  Predicting blending quality doesn't have to be a guessing game. Learn how to leverage virtual prototypes to make informed decisions and minimize costly trial-and-error in tablet manufacturing.

• Don't Let Your Filling Equipment Dictate Your Drug Formulation

  6/1/2026

  Gravimetric powder dosing measures true mass to eliminate equipment-driven reformulation, preserving particle design and speeding clinical development.

• Benefits Of Single-Use Isolators For Cytotoxic Payload Handling

  6/15/2026

  Managing cytotoxic ADC payloads in shared containment facilities creates mounting compliance, safety, and operational costs that single-use isolator technology is designed to address.